RxNorm Semantic Concepts Index - 354
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "354".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 354 | Adrenal cortical hormone-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 354 | Adrenal cortical hormone-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 354 | Adrenal cortical hormone-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 354 | Adrenal cortical hormone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 354 | Adrenal cortical hormone-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 354 | Adrenal cortical hormone-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 354 | Adrenal cortical hormone-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 35400 | Retinyl acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 35400 | Retinyl acetate | Designated preferred name (PT) | YES | |
| RxCUI: 35400 | Retinyl acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 35400 | Retinyl acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 354001 | Commit Lozenge | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 35402 | Retinol dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 35402 | Retinol dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 35403 | Retinol fatty-acyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 35403 | Retinol fatty-acyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 35404 | Retinol isomerase | Designated preferred name (PT) | NO | |
| RxCUI: 35404 | Retinol isomerase | Full form of descriptor (FN) | NO | |
| RxCUI: 35405 | Retinyl oleate | Designated preferred name (PT) | NO | |
| RxCUI: 35405 | Retinyl oleate | Full form of descriptor (FN) | NO | |
| RxCUI: 35405 | Retinyl oleate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35406 | Vitamin A palmitate | Designated preferred name (PT) | YES | |
| RxCUI: 35406 | Vitamin A palmitate | Full form of descriptor (FN) | YES | |
| RxCUI: 35406 | Vitamin A palmitate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 35406 | Vitamin A palmitate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 35406 | Vitamin A palmitate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3541 | Disopyramide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3541 | Disopyramide | Designated preferred name (PT) | YES | |
| RxCUI: 3541 | Disopyramide | Full form of descriptor (FN) | YES | |
| RxCUI: 3541 | Disopyramide | Designated preferred name (PT) | YES | |
| RxCUI: 3541 | Disopyramide | Full form of descriptor (FN) | YES | |
| RxCUI: 35410 | Retinyl-palmitate esterase | Designated preferred name (PT) | NO | |
| RxCUI: 35410 | Retinyl-palmitate esterase | Full form of descriptor (FN) | NO | |
| RxCUI: 35448 | Rhamnulokinase | Designated preferred name (PT) | NO | |
| RxCUI: 35448 | Rhamnulokinase | Full form of descriptor (FN) | NO | |
| RxCUI: 35449 | Rhamnulose-1-phosphate aldolase | Designated preferred name (PT) | NO | |
| RxCUI: 35449 | Rhamnulose-1-phosphate aldolase | Full form of descriptor (FN) | NO | |
| RxCUI: 354606 | emodepside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 354607 | Tirofiban hydrochloride monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 354607 | Tirofiban hydrochloride monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 35464 | Blood group antigen Rh>o< | Designated preferred name (PT) | NO | |
| RxCUI: 35464 | Blood group antigen Rh>o< | Full form of descriptor (FN) | NO | |
| RxCUI: 35464 | Blood group antigen Rh>o< | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35464 | Blood group antigen Rh>o< | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35464 | Blood group antigen Rh>o< | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35464 | Blood group antigen Rh>o< | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35465 | anti-D (Rh) immunoglobulin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 35465 | anti-D (Rh) immunoglobulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3547 | Solprin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 354770 | Natalizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 354770 | Natalizumab | Designated preferred name (PT) | YES | |
| RxCUI: 354770 | Natalizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 354770 | Natalizumab | Designated preferred name (PT) | YES | |
| RxCUI: 354770 | Natalizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 35483 | Opsin kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35483 | Opsin kinase | Designated preferred name (PT) | NO | |
| RxCUI: 35483 | Opsin kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 354841 | N-methyl valine | Designated preferred name (PT) | NO | |
| RxCUI: 354841 | N-methyl valine | Full form of descriptor (FN) | NO | |
| RxCUI: 35497 | Ribitol dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 35497 | Ribitol dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 35498 | Ribitol teichoic acid | Designated preferred name (PT) | NO | |
| RxCUI: 35498 | Ribitol teichoic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 35499 | Riboflavin phosphotransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 35499 | Riboflavin phosphotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 35499 | Riboflavin phosphotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 35499 | Riboflavin phosphotransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |